{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-009698","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.224943+00:00","generated_at":"2026-05-25T01:33:20.015945+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PAVmed subsidiary Lucid Diagnostics closes ~$15.3M equity offering at $1.10/share","bullets":["Lucid Diagnostics sold 13.9M shares at $1.10 each, gross proceeds ~$15.3M.","Net proceeds estimated ~$14.5M after placement agent fees and expenses.","Proceeds expected to be used for working capital and general corporate purposes.","Offering closed on March 5, 2025, pursuant to an existing shelf registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-009698","json":"https://secwatch.observer/filing/0001493152-25-009698.json","markdown":"https://secwatch.observer/filing/0001493152-25-009698.md","text":"https://secwatch.observer/filing/0001493152-25-009698.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315225009698/0001493152-25-009698-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315225009698/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T01:33:20.015945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}